Science Explorer Back to mapMap
Discussion
Researcher · Anhui Provincial Hospital · China

Chang-Lu Hu

Chang-Lu Hu publishes mostly in Oncology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers and Esophageal Cancer Research and Treatment.

OpenAlex
World rank
#760,504
of 7,710,434 ranked researchers
Rank in China
#101,767
of 978,568
Works
109
Citations
1.2k
Citations per work
10.6
h-index
16
i10-index 19Top 33% in Oncology
Chang-Lu Hu

What does Chang-Lu Hu research?

Chang-Lu Hu's work is mostly in Medicine (60%), Immunology and Microbiology (9%), Biochemistry, Genetics and Molecular Biology (5%).

Health Sciences: 66 works · 60.3% of their workMedicine: 66 works · 60.3% of their workOncology: 26 works · 24.3% of their workSurgery: 20 works · 18.0% of their workPulmonary and Respiratory Medicine: 15 works · 13.5% of their workPathology and Forensic Medicine: 5 works · 4.5% of their workEverything else: 28 works · 25.3% of their workLife Sciences: 16 works · 14.4% of their workImmunology and Microbiology: 10 works · 9.0% of their workImmunology: 10 works · 9.0% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 5.4% of their workMolecular Biology: 6 works · 5.4% of their workTHEIR WORKChang-Lu Hu109works
Life Sciences14%Health Sciences60%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine6660.3%
  2. Everything else2825.3%
    1. Immunology and Microbiology109.0%
    2. Biochemistry, Genetics and Molecular Biology65.4%
  1. 1Oncology24% of their works
  2. 2Surgery18% of their works
  3. 3Pulmonary and Respiratory Medicine14% of their works
  4. 4Immunology9% of their works
  5. 5Molecular Biology5% of their works
  6. 6Pathology and Forensic Medicine4% of their works

Research topics

Which keywords describe Chang-Lu Hu's research?

The keywords of their largest research topics: Chemotherapy, Neoadjuvant Therapy, Immunotherapy, Molecular Characterization, Endoscopic Resection, Epidemiology, Bladder Cancer and Breast Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 23 words, with their numbers
  1. Chemotherapy163 topics
  2. Neoadjuvant Therapy142 topics
  3. Immunotherapy122 topics
  4. Molecular Characterization122 topics
  5. Endoscopic Resection102 topics
  6. Epidemiology102 topics
  7. Bladder Cancer81 topic
  8. Breast Cancer82 topics
  9. Urothelial Carcinoma81 topic
  10. Esophageal Carcinoma61 topic
  11. Immune Checkpoint Blockade61 topic
  12. PD-1 and PD-L161 topic
  13. Preoperative Chemoradiotherapy61 topic
  14. EGFR Mutations51 topic
  15. Targeted Therapy51 topic
  16. CDK4/6 Inhibitors41 topic
  17. Gastric Cancer41 topic
  18. HER241 topic
  19. HTLV-141 topic
  20. Infection41 topic
  21. Lymph Node Dissection41 topic
  22. Palbociclib41 topic
  23. Trastuzumab41 topic

Where does Chang-Lu Hu work?

Chang-Lu Hu's main affiliation in the publication record is Anhui Provincial Hospital, China.

How many publications and citations does Chang-Lu Hu have?

OpenAlex counts 109 works and 1,153 citations for Chang-Lu Hu, an h-index of 16, ranking #760,504 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Chang-Lu Hu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.